Label: BENZEDREX- propylhexedrine inhalant
- NDC Code(s): 0225-0611-23
- Packager: BF ASCHER AND CO INC
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated December 5, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- ACTIVE INGREDIENT
- INDICATIONS & USAGE
- PURPOSE
-
WARNINGS
Warnings
- Do not exceed recommended dosage.
- This product may cause temporary discomfort such as burning, stinging, sneezing, or an increase in nasal discharge.
- The use of this container by more than one person may spread infection.
- Use only as directed.
- Frequent or prolonged use may cause nasal congestion to recur or worsen.
- Ill effects may result if taken internally
- DO NOT USE
- ASK DOCTOR
- PREGNANCY OR BREAST FEEDING
- KEEP OUT OF REACH OF CHILDREN
- DOSAGE & ADMINISTRATION
- INSTRUCTIONS FOR USE
- STORAGE AND HANDLING
- INACTIVE INGREDIENT
-
QUESTIONS
Questions?
Call 1-800-324-1880, 7:30am - 4:00pm Central, Mon. - Fri., or visit us at www.bfascher.com
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
BENZEDREX
propylhexedrine inhalantProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:0225-0611 Route of Administration NASAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength PROPYLHEXEDRINE (UNII: LQU92IU8LL) (PROPYLHEXEDRINE - UNII:LQU92IU8LL) PROPYLHEXEDRINE 175 mg Inactive Ingredients Ingredient Name Strength LAVENDER OIL (UNII: ZBP1YXW0H8) MENTHOL (UNII: L7T10EIP3A) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:0225-0611-23 1 in 1 INHALER; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.) 06/23/2023 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M012 06/23/2023 Labeler - BF ASCHER AND CO INC (003854403)

